Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.Title<sup>177</sup>Lu-lilotomab satetraxetan has the potential to counteract resistance to rituximab in non- Hodgkin's lymphoma.AuthorsMalenge, Marion M.; Patzke, Sebastian; Ree, Anne H.; Stokke, Trond; Ceuppens, Peter; Middleton, Brian; Dahle, Jostein; Repetto-Llamazares, Ada H. V.PublicationJournal of Nuclear Medicine, 2020, Vol 61, Issue 12, p1ISSN0161-5505Publication typeArticleDOI10.2967/jnumed.119.237230